Our team comprises renowned experts in gene therapy biosafety assessment. As innovators of industry-standard technologies for integration site analysis, we are forging the path for safer gene therapies.
We are at the beginning of a new era of precision medicine – this is exciting and challenging at the same time. We credit our highly committed team for the progress we have made so far. Join us in our quest to make gene therapies safer for patients.
GeneWerK’s journey began long before the company was officially founded in 2014 by Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt and Dr. Annette Deichmann, together with German Cancer Research Center (DKFZ).
Today, we are a team of >30 employees providing expertise and services to clients around the world from Heidelberg, Germany.View our history